<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 22, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02527226</url>
  </required_header>
  <id_info>
    <org_study_id>15-004441</org_study_id>
    <nct_id>NCT02527226</nct_id>
  </id_info>
  <brief_title>Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors</brief_title>
  <official_title>Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a protocol to govern the prospective trial of facial nerve monitoring in patients
      undergoing parotidectomy with an eye towards interpreting if the facial nerve monitor
      provides useful information to operating surgeons and if the information provided by the
      facial nerve monitor can predict degrees of postoperative facial nerve paresis.

      Additionally, the study will determine if performing daily facial rehabilitation exercises
      provides a benefit in reducing time to recovery of temporary post-parotidectomy paresis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Postoperative facial weakness</measure>
    <time_frame>postoperative day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measure degree of facial weakness on postop day 1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to resolution of facial weakness</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Monitor time to resolution of weakness in the facial exercises and control groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Parotid Neoplasms</condition>
  <condition>Facial Paralysis</condition>
  <arm_group>
    <arm_group_label>No facial exercises</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will not receive any training in facial exercises.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Facial exercises</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive instruction to perform a series of self-administered exercises of facial expression and movements.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Facial exercises</intervention_name>
    <description>A series of self-administered facial movements and expressions.</description>
    <arm_group_label>Facial exercises</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Planned parotid gland surgery (superficial or total parotidectomy)

          -  Benign or malignant disease

        Exclusion Criteria:

          -  Pregnancy

          -  Preoperative facial nerve dysfunction

          -  Revision operation

          -  History of preoperative radiation to the surgical field

          -  Entire nerve not dissected

          -  Intentional nerve sacrifice

          -  Poor signal to noise ratio during surgery

          -  Lack of access to device compatible with video conferencing software, or lack of
             access to broadband internet connection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Moore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brandon W Peck, MD</last_name>
    <email>Peck.Brandon@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Deep, MD</last_name>
      <email>Deep.Nicholas@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Peck, MD</last_name>
      <email>Peck.Brandon@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 15, 2016</lastchanged_date>
  <firstreceived_date>August 17, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Eric J. Moore, M.D.</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bell Palsy</mesh_term>
    <mesh_term>Facial Paralysis</mesh_term>
    <mesh_term>Facies</mesh_term>
    <mesh_term>Parotid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
